Sinovac Biotech (SVA) says that its current CFO, Mr. Danny Chung, has resigned for family reasons. Ms. Nan Wang has been appointed as his replacement, effective June 1. Ms. Wang oversaw SVA's business development, strategic management and investment. She was instrumental in leading the Company's successful public offering in early 2010.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs